SNBL - A Leading Company in Nasal Drug Delivery

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD TR Company

SYSTEMIC DRUGS VACCINES

NASAL DELIVERY PLATFORM TECHNOLOGY

BUSINESS

µco™ System (pronounced “Muco” System) is an innovative nasal delivery platform technology, consisting of an intranasal powder formulation and nasal delivery devices, suitable for a wide range of drugs.

RSYSTEMIC DRUGS

RESEARCH & DEVELOPMENT

For small molecules or peptides, µco™ System can provide improved bioavailability and rapid drug on-set.

VACCINES

DEVELOPMENT PIPELINE

For vaccines, µco™ System can effectively improve mucosal immunogenicity to defend against respiratory or mucosal infections.

PARTNERING

PARTNERING

µco™ System is available for use with your compounds. SNBL also offers a quick feasibility study using our well-established models to evaluate the applicability on your compounds with µco™ System.